A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)

Clinical trial NCT07755410 · RECRUITING

Trial details

NCT number: NCT07755410
Sponsor: Alkermes, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity (ADHD)

Start date: 2026-08-01
Primary completion: 2027-07-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.